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Understanding the patterns of mammography use and monitoring
changes in use are essential to improving national health policy for
breast cancer control. We aimed to describe the use of mammo-
graphy in Portugal and to identify the determinants of its nonuse
and underuse by examining data from the National Health Survey
2014.
Methods
We analyzed data on 8,758 women aged 30 years or older. We
defined women at an eligible age for mammography as women
aged 45 to 69. Women who reported a previous mammography
test were classified as ever-users and grouped according to time
since the most recent test. We computed the prevalence of mam-
mography use, and we used Poisson regression models to obtain
age-adjusted and education-adjusted prevalence ratios and 95%
confidence intervals.
Results
The overall prevalence of mammography use was 80.0%, whereas
nonuse was 20.0% and underuse 27.3% among users. The preval-
ence of nonuse and underuse were lower and associations with so-
ciodemographic characteristics, use of health care services, and
behavioral factors were stronger among women aged 45 to 69 than
among women aged 30 to 44 and women aged 70 or older. The
prevalence  of  mammography  use  was  generally  higher  in  the
northern areas of Portugal than in southern areas and varied by
marital status, educational level, and household size. A more fre-
quent use of health care services and healthier behaviors were as-
sociated with lower prevalences of both nonuse and underuse.
Conclusion
This  study  illustrates  inequalities  in  mammography  use  and
provides useful information for better allocation of resources in
breast cancer screening.
Introduction
Breast cancer is the most frequent cancer among women in the
world (1). It ranks first as cause of cancer death among women in
less developed regions and second as cause of cancer death in
more developed regions (2). Nevertheless, 5-year survival has in-
creased worldwide, surpassing 80% in several high-income coun-
tries (3). Besides the availability of more effective treatments, the
widespread use of mammography screening is also responsible for
these improvements (4).
The European Council recommends the screening of women aged
50 to 69 years through mammography every 2 years; organized
screening programs (ie,  population-based screening programs
aimed at the entire resident population of a given age range and
sex, designed to detect malignant disease during the detectable
preclinical phase [before the occurrence of symptoms], organized
at national or regional level, with an explicit policy, a team re-
sponsible for organization and for health care, and a structure for
quality assurance [5]) are intended to reduce inequalities in access
to early detection (6). Although these organized screening pro-
grams have been implemented in nearly all European Union coun-
tries, screening discrepancies exist, namely in coverage (ie, the
proportion of the targeted population invited to have a screening
according to the scheduled policy) and rates of participation (ie,
the number of women who have a screening test as a proportion of
all women who are invited to have a screening) (5,7). In Portugal
(8), regional screening programs have been implemented in Centro
since 1990, in Lisboa e Vale do Tejo since 1991, and in Alentejo
since 1997; programs started later in Algarve (2005) and in Norte
(2009). Except for in Algarve, where the Algarve Oncology Asso-
ciation (Associação Oncológica do Algarve) is responsible for the
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organized screening of women aged from 50 to 69, the other re-
gional  programs are conducted by the Portuguese Cancer League
(Liga Portuguesa Contra o Cancro) and target women aged 45 to
69 years. Nationally, geographic coverage has been increasing,
from about 55% in 2009 to 72% in 2015 (8), whereas adherence to
screening has slightly declined recently, from 64.5% in 2012 to
62% in 2015, and regional differences exist.
An evaluation of data from Portugal’s National Health Survey
2005–2006 concluded that the use of mammography among eli-
gible women (ie,  women aged 45 to 69) varied by region,  so-
ciodemographic characteristics, and access to and use of health
care services (9). Understanding the patterns of mammography use
and monitoring changes in use is essential to improving national
health policy for breast cancer control. This study aimed to de-
scribe the use of mammography by women in Portugal  and to
identify the determinants of its nonuse and underuse by examin-
ing data from the National Health Survey (NHS) 2014.
Methods
Our analysis was based on data collected as part of the NHS 2014,
which is a community-based cross-sectional study that evaluated a
sample,  obtained  through  multistage  stratified  and  cluster
sampling, of the population living in Portugal.
A sample of households was defined by using data from the 2011
Population  and  Housing  Census;  the  sample  was  used  as  the
sampling frame for household surveys conducted by Statistics Por-
tugal. The sample consisted of 1,183 primary sampling units, se-
lected systematically from larger geographical strata; the probabil-
ity of selecting a primary sampling unit was proportional to the
number  of  households  in  each  unit.  A  random sample  of  the
households was then selected, and all  people aged 15 years or
older living in these households at the date of the recruitment were
eligible to participate. In each household, the selected person was
the one whose previous birthday was closest to the date of the con-
tact. The sample size was defined to ensure a homogeneous distri-
bution of the participants among the 7 regions classified by NUTS
(Nomenclature of Territorial Units for Statistics) Level 2 (http://
ec.europa.eu/eurostat/documents/345175/7451602/nuts-map-
PT.pdf). The NUTS classification system is a hierarchical system
for dividing the economic territory of the European Union into re-
gions for the purpose of collecting and analyzing data (10).
From September  through December  2014,  22,538 households
were approached and 18,204 people (56.4% women) were sur-
veyed. All information was collected by using either computer-as-
sisted personal interviewing or computer-assisted web interview-
ing (50% in each stratum). The questionnaire covered 4 thematic
areas: health status, health care, health determinants, and income
and health expenses. Use of mammography testing was assessed
in a section on preventive care by asking 2 questions: “Have you
ever had a mammography (breast x-ray)?” and, if yes, “When was
the last time?” The latter question was followed by the response
options “in the last 12 months,” “between 1 year and less than 2
years,” “between 2 years and less than 3 years,” and “3 years or
more.” A total of 10,240 women provided information on mam-
mography use. We restricted our analyses to women aged 30 years
or older (n = 9,119). We further excluded data on 361 women for
whom data were missing on the determinants of interest; our final
sample consisted of 8,758 women. Women who reported having a
previous mammogram were classified as ever-users and grouped
further according to the time since the latest test: up to 2 years (in-
cluding the options “in the last 12 months,” “between 1 year and
less  than 2  years,”)  or  2  or  more  years  (including the  options
“between 2 years and less than 3 years,” and “3 years or more”).
The latter category (2 or more years) was defined as underuse.
We computed the prevalence of mammography testing and used
Poisson regression models to compute age-adjusted and education-
adjusted prevalence ratios (PRs) and 95% confidence intervals
(CIs) to assess the determinants of mammography nonuse and un-
deruse.  All  analyses  were  conducted  with  Stata  version  11.2
(StataCorp LP) by using sampling weights computed according to
design weight (ie, the inverse of the probability of selection of
each primary sampling unit and of each household in each primary
sampling unit, further corrected for nonresponse and for the effect-
ive number of participants evaluated, and taking into account the
age- and sex-structures). For the determinants of nonuse, analyses
were further stratified by age group. The analyses on determinants
of underuse were restricted to the age group most commonly tar-
geted by organized screening programs in Portugal (women aged
45 to 69).
Results
Nearly half of the women in the study sample were aged 45 to 69
and therefore potentially eligible for breast cancer screening (Ta-
ble 1). By education level, 14.5% had not completed a basic level
and  18.7%  had  completed  more  than  a  than  secondary  level.
Nearly 20% of the women had access to health care also through
other subsystems besides the national health system, and 17.8%
had a private health insurance.
The overall prevalence of mammography use was 80.0% (95% CI,
78.8%–81.3%),  whereas  nonuse  was  20.0%  (95%  CI,
18.7%–21.2%)  (Figure).  Of  women eligible  for  breast  cancer
screening in 2014, 96.2% (95% CI, 95.3%–97.0%) had ever re-
ceived a mammogram, and 3.8% (95% CI, 3.0%–4.6%) had never
had one. By age group, the lowest prevalences of nonuse were
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among  women  aged  45  to  69,  ranging  from  2.1%  (95%  CI,
0.8%–3.4%) for women aged 60 to 64 years to 5.6% (95% CI,
3.5%–7.7%) for women aged 45 to 49. Among ever-users, the pre-
valence of underuse was 27.3% (95% CI, 25.7%–28.8%); the pre-
valence was lowest among women aged 45 to 69 (13.1% [95% CI,
11.5%–14.7%]), ranging from 10.2% (95% CI, 7.5%–13.0%) for
women aged 60 to 64 years to 16.2% (95% CI, 12.5%–19.9%) for
women aged 65 to 69.
Figure. Prevalence of mammography use in Portugal among women aged 30
years or older, according to the elapsed time since most recent test, by age
group. Data are from the National Health Survey 2014.
 
Women aged 45 or older living in Alentejo, Algarve, RA Açores,
or RA Madeira were more likely than similarly aged women liv-
ing in Norte to never have had a mammogram (Table 2). Among
women aged 30 to 44, compared with women living in Norte, wo-
men living in RA Açores were more likely to never have had a
mammogram, but women living in Lisboa were less likely to nev-
er have had a mammogram. Among women aged 70 or older, the
prevalence of mammography nonuse was higher among women
living in areas of intermediate density or thinly populated areas
than among women in densely populated areas. Among women
aged 45 to 69, non-Portuguese women were more likely than Por-
tuguese women to never have had a mammogram.
Single women aged 45 to 69 were more likely than married wo-
men of that age to have never had a mammogram. By education
level, the prevalence of mammography nonuse was significantly
higher only among women with no basic educational level com-
pleted,  compared  with  the  highest  level  of  education,  except
among women aged 70 or older, for whom the prevalence of no-
nuse was higher  at  all  levels  of  education,  compared with the
highest level. Unemployed women at the time of the interview
were more likely than employed women to have never had a mam-
mogram in the age group 45 to 69. The prevalence of mammo-
graphy nonuse was higher among women aged 45 or older living
alone compared with similarly aged women in a household of 2
people. In the age group 30 to 44, the prevalence of nonuse was
significantly higher among women in the 2 lowest quintiles of
monthly household income per adult.
Women using only the NHS as their public health care provider
were more likely to have never had a mammogram in the group
aged 30 to 44, but we found no differences between women with
private insurance and women without a private health insurance in
any age group. In the age group 45 to 69, women who perceived
their health status as very poor were less likely than women who
perceived their health as fair to have never had a mammogram,
while the opposite was observed for those who considered their
health status as good or very good. In this same age group, wo-
men without a previous diagnosis of chronic disease were more
likely to have never had a mammogram. The prevalence of mam-
mography nonuse was significantly higher among women who
had their most recent appointment with a general practitioner or a
specialist physician more than one year before the interview and
among who had never had a cervical cytology test or fecal occult
blood test and/or colonoscopy in all age groups. Among women
aged 45 to 69 years, the prevalence of mammography nonuse was
higher among underweight women, compared with normal-weight
women, and lower in former drinkers, compared with never-drink-
ers.
Women aged 45 to 69 living in Lisboa, Alentejo, Algarve, RA
Açores, and RA Madeira were significantly more likely than sim-
ilarly aged women living in Norte to underuse mammography; so
were non-Portuguese women, compared with Portuguese women
(Table 3). Single and divorced women, compared with married
women, as well as those living in households consisting of more
than 4 people were more likely to underuse mammography. By
education level, the prevalence of mammography underuse was
the lowest among women who completed a second basic educa-
tional level.
Women who perceived themselves as having a very good health
were more likely than women who perceived their health as fair to
underuse mammography, as were women who had their most re-
cent appointment with a general practitioner or specialist physi-
cian more than one year before the interview and those who had
never had a cervical cytology test or fecal occult blood test and/or
colonoscopy.
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The prevalence of mammography underuse was higher among wo-
men eating fewer than 5 portions of fruits and vegetables per day,
compared with women who ate at least 5 portions, and among cur-
rent smokers, compared with never-smokers, whereas the oppos-
ite was found for former drinkers. Former drinkers were less likely
than never-drinkers to underuse mammography.
Discussion
Our data showed that 96.2% of women eligible for breast cancer
screening in 2014 had ever received a mammogram, an increase of
approximately 10% (from 87.6%) in mammography use since the
2005–2006 National Health Survey (9). However, a considerable
percentage of women have never had a mammogram or did not
follow screening. The prevalence of nonuse and underuse was
lower among women aged 45 to 69, the age targeted for screening,
than among women aged 30 to 44 and women aged 70 or older.
Regional variations persisted, and patterns of mammography use
differed according to sociodemographic characteristics and access
to and use of health care services.
Although the results of our study cannot be generalized to other
settings, because our data depended on how breast cancer screen-
ing is performed in Portugal, namely through implementation of
organized screening programs and local specificities of the health
care system, our findings are similar to those reported for other
countries  using comparable  methodologies.  Countries  such as
France (12), Italy (13), and Spain (14) reported similar preval-
ences of mammography use based on data from recent national
health surveys.
We  found  that  rates  of  mammography  nonuse  and  underuse
among women aged 45 to 69 years were higher in the southern re-
gions of Portugal than in the northern region. This finding is in ac-
cordance with a recent evaluation of the breast cancer screening
program in the northern region of Portugal (15), which showed a
participation rate of 74.5% in 2008–2009 and that most perform-
ance  indicators  were  consistent  with  levels  defined  by  the
European Guidelines (5). However, a report in 2016 on popula-
tion-based cancer screening programs in Portugal showed that
geographic and population coverage and adherence to screening
were at lower levels in the northern region than in other regions of
Portugal (approximately 80% and 53% vs 98% and 65%, respect-
ively) (8). Taking into account the report in 2016 and that organ-
ized screening in the northern region started later than screening in
other regions, the lower prevalence of mammography nonuse in
the northern region (2.9% among women aged 45 to 69 years),
compared with other regions, found in our study may have been
due to a higher prevalence of opportunistic screening in the north-
ern region than in other regions. Opportunistic screening is screen-
ing outside an organized or population-based screening program,
for example, following a recommendation made during a routine
medical consultation, or a consultation for an unrelated condition
revealing a potentially increased risk of cancer, or by self-referral.
In addition, the territorial units defined by NUTS 2 do not entirely
correspond to regions covered by the regional health administra-
tion responsible for implementing breast cancer screening pro-
grams. Some territorial differences between geographic regions
and health regions may translate into an overestimation of mam-
mography use in Lisboa and an underestimation in Centro. Never-
theless, our findings show that regional gaps exist and demon-
strate insufficient coverage and/or insufficient participation by eli-
gible women.
Our results are in line with previous evaluations of breast cancer
screening uptake by national health surveys, identifying poorer so-
cioeconomic status and lower levels of use of health care services
as the main determinants of mammography testing (12,16–19). On
one hand, the prevalence of nonuse by education level was highest
among women with no basic level of education completed, and we
observed no significant differences according to income. Other
studies also showed no association between women’s economic
situation and adherence to breast cancer screening recommenda-
tions (20). On the other hand, greater use of health care services,
such as a recent interaction with a usual health care provider and
ever having had a cervical cytology test, was associated with low
prevalences of mammography nonuse and underuse.  Although
these associations were also reported in other studies (12,16–19),
we additionally found that women who had ever had a fecal oc-
cult blood test and/or colonoscopy were also more likely to have
received a mammogram. These findings suggest that the closer
women are to the health care system, the easier is the process of
becoming aware of the importance of monitoring breast cancer
and that women should be encouraged to maintain regular contact
with their family physicians. Our results also confirmed that po-
tentially easier access to the health care system is associated with a
lower risk of not being screened, at least among younger women.
Other sociodemographic characteristics were identified as determ-
inants of mammography use in our study, namely the degree of
urbanization among older women. Other studies that account for
population density support our findings (12,21). In our study, only
marital information on legal marital status was available. Other
studies have provided details on women’s living arrangements (eg,
living alone, living with partner), regardless of their legal marital
status as single women (22). Therefore, a direct comparison of our
results with the results of most other studies cannot be made, but
our findings on legal marital status are consistent with our find-
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ings on household size. Mammography testing was less frequent
among non-Portuguese women than among Portuguese women,
consistent with the findings of several studies that identified im-
migrants as a vulnerable population in this context (12,18,19,23).
In our study, the prevalence of mammography nonuse increased as
self-perceived health status improved, consistent with a study in
Italy (24). These results point to the possible need for additional
primary prevention efforts among women who perceive them-
selves as being healthy in the age group considered to be at higher
risk for developing breast cancer (ie, women aged 45 to 69). It was
also in this age group that the prevalence of nonuse was higher
among women without a diagnosis of chronic disease than among
women with such a diagnosis. Other studies reported similar find-
ings (14,16), and, although differences according to the type of
chronic disease were described (17,19,25,26), our results may in-
dicate over-screening among women with a chronic disease. Re-
search also consistently shows that obese women are less likely to
undergo  breast  cancer  screening  than  nonobese  women
(16,18,24–26), but in our study the highest prevalence of nonuse
was among underweight women.
Other studies have also reported higher levels of adherence to
breast cancer screening among those who have healthy lifestyles,
namely women who are physically active (14,17); however, re-
search on the relationship between adherence and diet is less con-
sistent (17). Our study found a significant positive association
between mammography underuse and not following recommenda-
tions on fruit and vegetables intake (27) but only among women in
the age range targeted for screening (aged 45 to 69). In our study,
former drinkers were less likely than never-drinkers to underuse or
not use mammography; this finding may conflict with those of a
study in Spain (14), however, in the latter, only information on
current  alcohol  consumption was  provided.  Similarly,  current
smokers were more likely to underuse mammography in our ana-
lysis.  Only one study showed an association between smoking
status and breast cancer screening uptake in line with our results
(12); most studies reported no difference in adherence according
to this lifestyle factor (24,25).
The main strength of this study is the evaluation of a large repres-
entative sample of women living in Portugal. The study provides
information on patterns of mammography use and identifies the
major determinants of use. These data can be used to improve the
national health policy for breast cancer screening. However, this
study also has several limitations. Although the 2 questions on
mammography use in the NHS 2014 were part of a section refer-
ring to preventive care, we cannot ascertain that all women who
reported having mammogram had one for screening purposes and
not for diagnostic purposes. As a result, we may have underestim-
ated the prevalence of mammography nonuse for screening pur-
poses.  Furthermore,  even if  all  women who reported having a
mammogram had one for screening purposes, no survey question
asked whether the mammogram was received through an organ-
ized screening program or through opportunistic screening. This
precludes a direct comparison of our results with the results of pre-
vious evaluations of organized screening programs and comparis-
ons  between  organized  screening  programs  and  opportunistic
screening (13,26). Additionally, no information on personal or
family history of breast cancer was collected; this information
could have influenced cancer screening initiation and frequency,
especially among younger women.
Although our results showed an increase in mammography use in
the last 10 years in Portugal, regional differences persist, espe-
cially among women in the age range most commonly targeted by
organized screening programs conducted at the national level. Dif-
ferences according to sociodemographic characteristics and ac-
cess to and use of health care services illustrate inequalities in
mammography testing. This study provides useful information for
a better allocation of resources for breast cancer screening, namely
taking into account the regional and socioeconomic factors identi-
fied as possible barriers.
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Tables
Table 1. Characteristics of the Sample and Prevalence of Mammography Use Among Women Aged ≥30, National Health Survey, Portugal, 2014




Overall 8,758 — — 80.0 (78.8-81.3)
Region of residence (NUTS 2)
Norte 1,326 15.1 34.8 79.9 (77.4–82.3)
Centro 1,800 20.6 22.1 81.7 (79.5–83.8)
Lisboa 971 11.1 27.2 83.8 (81.1–86.4)
Alentejo 1,332 15.2 7.3 75.1 (72.4–77.8)
Algarve 1,231 14.1 4.2 69.6 (66.6–72.6)
RA Açores 947 10.8 2.0 65.8 (62.2–69.3)
RA Madeira 1,151 13.1 2.4 70.9 (67.8–74.0)
Degree of urbanizationb
Densely populated area 2,669 30.5 44.2 82.9 (80.9–84.9)
Intermediate density area 2,872 32.8 28.8 77.6 (75.3–80.0)
Thinly populated area 3,217 36.7 26.9 77.9 (75.7–80.1)
Nationality
Portuguese 8,577 97.9 98.1 80.3 (79.0–81.5)
Other 181 2.1 1.9 68.2 (58.3–78.0)
Age, y
30–44 2,253 25.7 30.1 54.9 (52.0–57.8)
45–49 774 8.8 10.3 94.4 (92.2–96.5)
50–54 818 9.3 10.4 97.2 (95.8–98.5)
55–59 790 9.0 9.6 96.1 (94.2–98.1)
60–64 869 9.9 8.8 97.9 (96.6–99.2)
65–69 846 9.7 8.2 95.3 (93.2–97.4)
≥70 2,408 27.5 22.5 79.8 (77.3–82.3)
Legal marital status
Single 1,273 14.5 13.7 59.4 (55.1–63.6)
Married 4,541 51.8 63.3 83.5 (82.1–85.0)
Divorced 965 11.0 8.9 86.8 (83.6–90.0)
Widowed 1,979 22.6 14.1 80.2 (77.3–83.0)
Abbreviations: CI, confidence interval; NUTS 2, Nomenclature of Territorial Units for Statistics, level 2; RA, Região Autónoma (autonomous region).
a Sampling weights were computed according to design weight (ie, the inverse of the probability of selection of each primary sampling unit and of each household
in each primary sampling unit, further corrected for nonresponse and for the effective number of participants evaluated, and taking into account the age and sex
structures).
b Based on the share of local population living in urban clusters and in urban centers according to Commission Directorates-General for Regional and Urban Policy,
Agriculture and Rural Development, Eurostat, Joint Research Centre, and the Organisation for Economic Co-operation and Development.
c Self-reported weight and height were used to compute body mass index (kg/m2), which was divided into 3 categories according to the World Health Organization
guidelines (11).
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Table 1. Characteristics of the Sample and Prevalence of Mammography Use Among Women Aged ≥30, National Health Survey, Portugal, 2014





No basic level completed 1,557 17.8 14.5 76.7 (73.5–80.0)
Second basic level completed 3,555 40.6 37.7 89.0 (87.4–90.5)
Third basic level completed 1,056 12.1 13.6 78.5 (74.9–82.0)
Secondary level completed 1,168 13.3 15.5 73.6 (70.0–77.1)
Higher than secondary level completed 1,422 16.2 18.7 71.2 (67.8–74.6)
Employment status
Employed 3,520 40.2 45.2 75.5 (73.5–77.6)
Unemployed 834 9.5 11.1 74.0 (69.8–78.2)
Retired or disabled 3,274 37.4 31.3 85.8 (84.0–87.7)
Housewife 1,130 12.9 12.3 87.3 (84.4–90.2)
No. of people living in household, including respondent
1 2,533 28.9 13.9 78.4 (76.1–80.7)
2 3,072 35.1 32.9 87.0 (85.4–88.6)
3 1,678 19.2 28.0 76.6 (74.0–79.4)
4 1,089 12.4 17.6 76.8 (73.4–80.1)
>4 386 4.4 7.5 72.8 (66.5–79.0)
Household income per adult
Quintile 1 2,025 23.1 20.7 78.3 (75.6–81.1)
Quintile 2 1,871 21.4 20.7 79.6 (77.0–82.2)
Quintile 3 1,807 20.6 20.7 80.9 (78.1–83.6)
Quintile 4 1,515 17.3 18.5 80.2 (77.2–83.1)
Quintile 5 1,540 17.6 19.4 81.4 (78.6–84.2)
Public health care provider
Only national health system 7,039 80.4 80.8 78.1 (76.7–79.5)
National health system and other subsystem 1,719 19.6 19.2 88.2 (86.0–90.4)
Private health insurance
No 7,456 85.1 82.2 80.8 (79.5–82.1)
Yes 1,302 14.9 17.8 76.5 (73.3–79.8)
Self-perceived health status
Very poor 467 5.3 4.9 86.0 (83.5–88.6)
Abbreviations: CI, confidence interval; NUTS 2, Nomenclature of Territorial Units for Statistics, level 2; RA, Região Autónoma (autonomous region).
a Sampling weights were computed according to design weight (ie, the inverse of the probability of selection of each primary sampling unit and of each household
in each primary sampling unit, further corrected for nonresponse and for the effective number of participants evaluated, and taking into account the age and sex
structures).
b Based on the share of local population living in urban clusters and in urban centers according to Commission Directorates-General for Regional and Urban Policy,
Agriculture and Rural Development, Eurostat, Joint Research Centre, and the Organisation for Economic Co-operation and Development.
c Self-reported weight and height were used to compute body mass index (kg/m2), which was divided into 3 categories according to the World Health Organization
guidelines (11).
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Table 1. Characteristics of the Sample and Prevalence of Mammography Use Among Women Aged ≥30, National Health Survey, Portugal, 2014




Poor 1,433 16.4 14.3 86.6 (85.0–88.2)
Fair 3,895 44.5 42.9 87.9 (83.6–92.2)
Good 2,409 27.5 31.0 70.9 (68.3–73.6)
Very good 554 6.3 6.9 62.4 (56.4–68.3)
Diagnosis of chronic disease
No 2,525 28.8 32.2 71.4 (68.8–73.9)
Yes 6,233 71.2 67.8 84.2 (82.8–85.5)
Most recent appointment with general practitioner
More than 1 year ago (includes never) 1,725 19.7 17.4 69.6 (66.3–73.0)
In the past year 7,033 80.3 82.6 82.2 (80.9–83.6)
Last appointment with specialist physician
More than 1 year ago (includes never) 4,125 47.1 44.3 77.3 (75.4–79.2)
In the past year 4,633 52.9 55.7 82.2 (80.6–83.8)
Cervical cytology test
Never 2,771 31.6 21.6 66.3 (63.4–62.3)
Ever (at least once) 5,987 68.4 78.4 83.8 (82.5–85.2)
Fecal occult blood test and/or colonoscopy
Never 4,967 56.7 52.2 71.0 (69.1–73.0)
Ever (at least once) 3,791 43.3 47.8 89.9 (88.5–91.3)
Body mass indexc
<18.5 148 1.7 1.6 65.2 (53.4–76.9)
18.5–24.9 3,574 40.8 43.6 74.9 (72.8–77.0)
25.0–29.9 3,168 36.2 35.3 83.6 (81.7–85.4)
≥30.0 1,868 21.3 19.5 86.4 (84.2–88.7)
No. of portions of fruits and vegetables per day
<5 6,989 79.8 77.7 78.8 (77.3–80.2)
≥5 1,769 20.2 22.3 84.5 (82.1–86.9)
Smoking status
Never 6,695 76.5 74.7 81.1 (79.6–82.5)
Former 1,020 11.6 13.3 80.1 (76.6–83.6)
Current 1,043 11.9 12.0 73.7 (69.8–77.6)
Abbreviations: CI, confidence interval; NUTS 2, Nomenclature of Territorial Units for Statistics, level 2; RA, Região Autónoma (autonomous region).
a Sampling weights were computed according to design weight (ie, the inverse of the probability of selection of each primary sampling unit and of each household
in each primary sampling unit, further corrected for nonresponse and for the effective number of participants evaluated, and taking into account the age and sex
structures).
b Based on the share of local population living in urban clusters and in urban centers according to Commission Directorates-General for Regional and Urban Policy,
Agriculture and Rural Development, Eurostat, Joint Research Centre, and the Organisation for Economic Co-operation and Development.
c Self-reported weight and height were used to compute body mass index (kg/m2), which was divided into 3 categories according to the World Health Organization
guidelines (11).
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Table 1. Characteristics of the Sample and Prevalence of Mammography Use Among Women Aged ≥30, National Health Survey, Portugal, 2014





Never 3,406 38.9 31.8 80.0 (78.0–82.0)
Former 999 11.4 12.3 79.3 (75.6–83.1)
Current 4,353 49.7 55.9 80.2 (78.5–81.9)
Abbreviations: CI, confidence interval; NUTS 2, Nomenclature of Territorial Units for Statistics, level 2; RA, Região Autónoma (autonomous region).
a Sampling weights were computed according to design weight (ie, the inverse of the probability of selection of each primary sampling unit and of each household
in each primary sampling unit, further corrected for nonresponse and for the effective number of participants evaluated, and taking into account the age and sex
structures).
b Based on the share of local population living in urban clusters and in urban centers according to Commission Directorates-General for Regional and Urban Policy,
Agriculture and Rural Development, Eurostat, Joint Research Centre, and the Organisation for Economic Co-operation and Development.
c Self-reported weight and height were used to compute body mass index (kg/m2), which was divided into 3 categories according to the World Health Organization
guidelines (11).
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Table 2. Determinants of Mammography Nonuse Among Women Aged 30 Years or Older, by Age Group, Portugal, 2014
Characteristic
Aged 30–44 (n = 2,253) Aged 45–69 (n = 4,097) Aged ≥ 70 (n = 2,408)
% Adjusted PRa (95% CI) % Adjusted PRa (95% CI) % Adjusted PRa (95% CI)
Region of residence (NUTS 2)
Norte 48.7 1 [Reference] 2.9 1 [Reference] 19.0 1 [Reference]
Centro 42.8 0.87 (0.74–1.01) 3.2 1.06 (0.54–2.08) 19.5 0.99 (0.71–1.36)
Lisboa 36.1 0.72 (0.59–0.87) 3.4 1.24 (0.59–2.61) 14.6 0.85 (0.55–1.30)
Alentejo 51.6 1.04 (0.88–1.23) 6.1 2.13 (1.17–3.86) 29.4 1.39 (1.03–1.88)
Algarve 56.8 1.14 (0.97–1.32) 9.6 3.29 (1.89–5.75) 35.6 1.82 (1.36–2.45)
RA Açores 66.2 1.32 (1.14–1.51) 8.2 2.87 (1.56–5.27) 35.4 1.88 (1.31–2.68)
RA Madeira 57.2 1.16 (0.99–1.35) 8.7 2.88 (1.62–5.10) 32.4 1.64 (1.19–2.25)
Degree of urbanizationb
Densely populated area 41.3 1 [Reference] 3.4 1 [Reference] 14.0 1 [Reference]
Intermediate density area 48.7 1.15 (1.00–1.33) 4.0 1.18 (0.69–2.02) 21.6 1.58 (1.14–2.20)
Thinly populated area 47.3 1.11 (0.96–1.29) 4.4 1.18 (0.70–2.00) 26.9 1.75 (1.30–2.35)
Nationality
Portuguese 45.1 1 [Reference] 0.4 1 [Reference] 20.2 1 [Reference]
Other 45.1 0.97 (0.71–1.32) 14.5 3.84 (1.63–9.05) — —
Legal marital status
Married 42.7 1 [Reference] 2.6 1 [Reference] 12.9 1 [Reference]
Single 57.4 1.06 (0.92–1.20) 15.4 6.06 (3.82–9.62) 30.5 1.54 (1.00–2.35)
Divorced 32.1 0.80 (0.62–1.01) 2.7 1.15 (0.64–2.06) 6.4 0.67 (0.30–1.47)
Widowed 24.9 0.90 (0.38–2.12) 3.7 1.39 (0.72–2.70) 26.5 1.36 (1.00–1.83)
Educational level
Higher than secondary level completed 48.7 1 [Reference] 3.0 1 [Reference] 2.1 1 [Reference]
Secondary level completed 44.1 0.95 (0.82–1.11) 3.2 1.11 (0.50–2.46) 22.6 10.27 (3.16–33.37)
Third basic level completed 45.2 0.95 (0.80–1.13) 5.2 1.81 (0.83–3.92) 10.1 4.39 (1.38–13.96)
Second basic level completed 38.0 0.95 (0.78–1.15) 3.3 1.28 (0.66–2.50) 15.5 7.00 (2.66–18.40)
No basic level completed 71.8 1.49 (1.05–2.12) 8.2 3.29 (1.41–7.69) 26.3 10.12 (3.90–26.28)
Employment status
Employed 44.8 1 [Reference] 3.6 1 [Reference] 18.6 1 [Reference]
Unemployed 46.6 1.03 (0.89–1.20) 6.4 1.82 (1.01–3.38) — —
Retired or disabled 41.8 0.83 (0.46–1.50) 2.8 0.64 (0.26–1.55) 20.2 1.07 (0.17–6.79)
Housewife 45.5 1.00 (0.70–1.42) 4.3 1.09 (0.56–2.12) 20.2 1.17 (0.18–7.54)
No. of people living in household, including respondent
Abbreviations: CI, confidence interval; NUTS 2, Nomenclature of Territorial Units for Statistics, level 2; PR, prevalence ratio; RA, Região Autónoma (autonomous re-
gion).
a Adjusted for age and education, except in education strata.
b Based on the share of local population living in urban clusters and in urban centers according to Commission Directorates-General for Regional and Urban Policy,
Agriculture and Rural Development, Eurostat, Joint Research Centre, and the Organisation for Economic Co-operation and Development.
c Self-reported weight and height were used to compute body mass index (kg/m2), which was divided into 3 categories according to the World Health Organization
guidelines (11).
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Table 2. Determinants of Mammography Nonuse Among Women Aged 30 Years or Older, by Age Group, Portugal, 2014
Characteristic
Aged 30–44 (n = 2,253) Aged 45–69 (n = 4,097) Aged ≥ 70 (n = 2,408)
% Adjusted PRa (95% CI) % Adjusted PRa (95% CI) % Adjusted PRa (95% CI)
2 50.9 1 [Reference] 3.1 1 [Reference] 14.6 1 [Reference]
1 54.7 1.07 (0.88–1.30) 5.4 1.77 (1.10–2.84) 25.0 1.34 (1.04–1.71)
3 47.5 0.93 (0.80–1.09) 3.5 1.07 (0.55–2.10) 25.6 1.28 (0.86–1.92)
4 37.1 0.88 (0.74–1.05) 5.0 1.51 (0.71–3.21) 18.9 1.15 (0.50–2.62)
>4 47.9 1.01 (0.77–1.32) 4.9 1.57 (0.66–3.75) 24.2 1.59 (0.77–3.29)
Household income per adult
Quintile 5 42.1 1 [Reference] 2.9 1 [Reference] 11.3 1 [Reference]
Quintile 4 43.8 1.04 (0.86–1.25) 3.8 1.27 (0.53–3.03) 11.6 0.72 (0.33–1.57)
Quintile 3 42.9 1.13 (0.92–1.39) 2.9 0.93 (0.39–2.18) 18.6 1.08 (0.57–2.06)
Quintile 2 53.0 1.42 (1.18–1.72) 3.4 1.07 (0.43–2.67) 21.2 1.24 (0.66–2.35)
Quintile 1 46.4 1.26 (1.01–1.57) 6.0 1.78 (0.72–4.40) 28.8 1.53 (0.81–2.89)
Public health care provider
National health system and other
subsystem
33.3 1 [Reference] 2.9 1 [Reference] 10.2 1 [Reference]
Only national health system 47.4 1.29 (1.06–1.58) 4.1 1.18 (0.56–2.47) 21.8 1.27 (0.74–2.17)
Private health insurance
Yes 43.2 1 [Reference] 3.3 1 [Reference] 9.5 1 [Reference]
No 45.9 1.10 (0.96–1.26) 4.0 1.11 (0.56–2.21) 20.6 0.97 (0.50–1.88)
Self-perceived health status
Fair 38.7 1 [Reference] 3.0 1 [Reference] 17.8 1 [Reference]
Very poor 27.7 0.72 (0.33–1.57) 1.0 0.29 (0.11–0.76) 17.2 0.89 (0.61–1.30)
Poor 23.8 0.66 (0.40–1.10) 2.2 0.65 (0.31–1.36) 23.6 1.17 (0.90–1.51)
Good 48.1 1.13 (0.97–1.32) 5.5 2.12 (1.27–3.53) 24.2 1.44 (0.99–2.10)
Very good 51.6 1.19 (0.96–1.47) 10.3 4.47 (2.04–9.80) 21.5 1.46 (0.77–2.77)
Diagnosis of chronic disease
Yes 42.4 1 [Reference] 2.8 1 [Reference] 20.1 1 [Reference]
No 47.3 1.04 (0.92–1.18) 6.5 2.54 (1.56–4.13) 20.7 1.27 (0.88–1.81)
Most recent appointment with general practitioner
In the past year 43.7 1 [Reference] 2.8 1 [Reference] 18.1 1 [Reference]
More than 1 year ago (includes never) 49.4 1.16 (1.01–1.32) 9.2 3.27 (2.12–5.04) 39.5 2.01 (1.58–2.54)
Most recent appointment with specialist physician
In the past year 41.8 1 [Reference] 2.2 1 [Reference] 15.7 1 [Reference]
More than 1 year ago (includes never) 49.8 1.22 (1.08–1.39) 5.7 2.42 (1.53–3.83) 26.0 1.52 (1.21–1.92)
Abbreviations: CI, confidence interval; NUTS 2, Nomenclature of Territorial Units for Statistics, level 2; PR, prevalence ratio; RA, Região Autónoma (autonomous re-
gion).
a Adjusted for age and education, except in education strata.
b Based on the share of local population living in urban clusters and in urban centers according to Commission Directorates-General for Regional and Urban Policy,
Agriculture and Rural Development, Eurostat, Joint Research Centre, and the Organisation for Economic Co-operation and Development.
c Self-reported weight and height were used to compute body mass index (kg/m2), which was divided into 3 categories according to the World Health Organization
guidelines (11).
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Table 2. Determinants of Mammography Nonuse Among Women Aged 30 Years or Older, by Age Group, Portugal, 2014
Characteristic
Aged 30–44 (n = 2,253) Aged 45–69 (n = 4,097) Aged ≥ 70 (n = 2,408)
% Adjusted PRa (95% CI) % Adjusted PRa (95% CI) % Adjusted PRa (95% CI)
Cervical cytology test
Ever (at least once) 43.2 1 [Reference] 1.4 1 [Reference] 3.6 1 [Reference]
Never 61.8 1.28 (1.08–1.52) 17.0 12.23 (7.86–19.03) 36.8 7.76 (4.42–13.61)
Fecal occult blood test and/or colonoscopy
Ever (at least once) 36.9 1 [Reference] 1.3 1 [Reference] 13.1 1 [Reference]
Never 47.7 1.20 (1.02–1.42) 7.2 5.18 (3.03–8.88) 30.8 2.12 (1.66–2.71)
Body mass indexc
18.5–24.9 47.3 1 [Reference] 3.8 1 [Reference] 23.2 1 [Reference]
<18.5 39.6 0.87 (0.54–1.41) 16.2 4.20 (1.42–12.39) 45.5 1.67 (0.97–2.87)
25.0–29.9 41.5 0.96 (0.83–1.12) 4.0 1.04 (0.62–1.74) 19.0 0.91 (0.71–1.18)
≥30.0 43.6 1.02 (0.84–1.24) 3.1 0.78 (0.46–1.35) 14.4 0.71 (0.51–1.00)
No. of portions of fruits and vegetables per day
≥5 42.4 1 [Reference] 2.2 1 [Reference] 13.5 1 [Reference]
<5 45.8 1.01 (0.87–1.18) 4.4 1.90 (1.00–3.61) 21.4 1.17 (0.82–1.69)
Smoking status
Never 45.1 1 [Reference] 3.9 1 [Reference] 20.9 1 [Reference]
Former 42.0 0.90 (0.76–1.07) 2.5 0.66 (0.32–1.33) 8.9 0.64 (0.30–1.39)
Current 48.0 1.06 (0.92–1.22) 4.8 1.24 (0.67–2.27) 4.5 0.32 (0.10–1.08)
Drinking status
Never 44.3 1 [Reference] 4.3 1 [Reference] 21.8 1 [Reference]
Former 46.8 1.04 (0.83–1.29) 2.3 0.50 (0.28–0.88) 24.0 1.12 (0.84–1.51)
Current 45.2 1.04 (0.90–1.19) 3.9 0.95 (0.61–1.47) 16.8 0.81 (0.62–1.06)
Abbreviations: CI, confidence interval; NUTS 2, Nomenclature of Territorial Units for Statistics, level 2; PR, prevalence ratio; RA, Região Autónoma (autonomous re-
gion).
a Adjusted for age and education, except in education strata.
b Based on the share of local population living in urban clusters and in urban centers according to Commission Directorates-General for Regional and Urban Policy,
Agriculture and Rural Development, Eurostat, Joint Research Centre, and the Organisation for Economic Co-operation and Development.
c Self-reported weight and height were used to compute body mass index (kg/m2), which was divided into 3 categories according to the World Health Organization
guidelines (11).
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Table 3. Determinants of Mammography Underusea Among Women Aged 45–69 Years (n = 4,097) Who Reported Having Had a Previous Mammography, Portugal,
2014
Characteristic % Adjusted PRb (95% CI)
Region of residence (NUTS 2)
Norte 8.4 1 [Reference]
Centro 12.5 1.45 (1.00–2.10)
Lisboa 17.4 1.95 (1.35–2.83)
Alentejo 14.8 1.74 (1.22–2.48)
Algarve 20.5 2.40 (1.70–3.39)
RA Açores 14.6 1.73 (1.19–2.52)
RA Madeira 22.8 2.65 (1.89–3.71)
Degree of urbanizationc
Densely populated area 13.4 1 [Reference]
Intermediate density area 12.0 0.97 (0.72–1.30)
Thinly populated area 13.8 1.12 (0.84–1.48)
Nationality
Portuguese 12.8 1 [Reference]
Other 30.8 2.34 (1.30–4.23)
Legal marital status
Married 11.2 1 [Reference]
Single 22.1 1.87 (1.31–2.68)
Divorced 17.3 1.52 (1.05–2.20)
Widowed 15.4 1.36 (0.96–1.92)
Educational level
Higher than secondary level completed 16.4 1 [Reference]
Secondary level completed 14.3 0.89 (0.56–1.42)
Third basic level completed 13.0 0.80 (0.52–1.22)
Second basic level completed 11.0 0.68 (0.48–0.97)
No basic level completed 19.2 1.13 (0.70–1.84)
Employment status
Employed 13.4 1 [Reference]
Unemployed 15.7 1.26 (0.86–1.87)
Retired or disabled 12.8 0.78 (0.52–1.18)
Housewife 10.9 0.81 (0.55–1.20)
No. of people living in household, including respondent
Abbreviations: CI, confidence interval; NUTS 2, Nomenclature of Territorial Units for Statistics, level 2; PR, prevalence ratio; RA, Região Autónoma (autonomous re-
gion).
a Most recent mammography performed 2 or more years ago.
b Adjusted for age and education, except in education strata.
c Based on the share of local population living in urban clusters and in urban centers according to Commission Directorates-General for Regional and Urban Policy,
Agriculture and Rural Development, Eurostat, Joint Research Centre, and the Organisation for Economic Co-operation and Development.
d Self-reported weight and height were used to compute body mass index (kg/m2), which was divided into 3 categories according to the World Health Organization
guidelines (11).
(continued on next page)
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(continued)
Table 3. Determinants of Mammography Underusea Among Women Aged 45–69 Years (n = 4,097) Who Reported Having Had a Previous Mammography, Portugal,
2014
Characteristic % Adjusted PRb (95% CI)
2 12.7 1 [Reference]
1 14.7 1.08 (0.82–1.43)
3 13.3 1.04 (0.76–1.43)
4 8.7 0.64 (0.39–1.06)
>4 22.2 1.79 (1.08–2.96)
Household income per adult
Quintile 5 12.2 1 [Reference]
Quintile 4 13.7 1.39 (0.89–2.18)
Quintile 3 12.5 1.37 (0.83–2.25)
Quintile 2 13.1 1.47 (0.89–2.42)
Quintile 1 13.9 1.61 (0.97–2.68)
Public health care provider
National health system and other subsystem 13.3 1 [Reference]
Only national health system 13.0 1.17 (0.82–1.68)
Private health insurance
Yes 12.8 1 [Reference]
No 13.1 1.14 (0.80–1.61)
Self-perceived health status
Fair 12.0 1 [Reference]
Very poor 14.0 1.12 (0.64–1.97)
Poor 11.3 0.94 (0.65–1.35)
Good 13.9 1.11 (0.80–1.55)
Very good 25.7 2.01 (1.28–3.15)
Diagnosis of chronic disease
Yes 12.4 1 [Reference]
No 14.8 1.14 (0.86–1.52)
Most recent appointment with general practitioner
In the past year 10.5 1 [Reference]
More than 1 year ago (includes never) 27.1 2.50 (1.91–3.27)
Most recent appointment with specialist physician
In the past year 10.4 1 [Reference]
More than 1 year ago (includes never) 16.3 1.62 (1.26–2.08)
Abbreviations: CI, confidence interval; NUTS 2, Nomenclature of Territorial Units for Statistics, level 2; PR, prevalence ratio; RA, Região Autónoma (autonomous re-
gion).
a Most recent mammography performed 2 or more years ago.
b Adjusted for age and education, except in education strata.
c Based on the share of local population living in urban clusters and in urban centers according to Commission Directorates-General for Regional and Urban Policy,
Agriculture and Rural Development, Eurostat, Joint Research Centre, and the Organisation for Economic Co-operation and Development.
d Self-reported weight and height were used to compute body mass index (kg/m2), which was divided into 3 categories according to the World Health Organization
guidelines (11).
(continued on next page)
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(continued)
Table 3. Determinants of Mammography Underusea Among Women Aged 45–69 Years (n = 4,097) Who Reported Having Had a Previous Mammography, Portugal,
2014
Characteristic % Adjusted PRb (95% CI)
Cervical cytology test
Ever (at least once) 11.6 1 [Reference]
Never 22.8 1.98 (1.52–2.57)
Fecal occult blood test and/or colonoscopy
Ever (at least once) 9.8 1 [Reference]
Never 17.8 1.82 (1.43–2.33)
Body mass indexd
18.5–24.9 13.6 1 [Reference]
<18.5 18.9 1.35 (0.58–3.14)
25.0–29.9 12.8 0.97 (0.72–1.31)
≥30.0 12.6 0.98 (0.70–1.37)
No. of portions of fruits and vegetables per day
≥5 10.3 1 [Reference]
<5 14.1 1.45 (1.06–1.97)
Smoking status
Never 12.0 1 [Reference]
Former 13.4 1.06 (0.72–1.57)
Current 19.4 1.59 (1.12–2.25)
Drinking status
Never 14.6 1 [Reference]
Former 8.3 0.58 (0.36–0.94)
Current 13.2 0.90 (0.69–1.17)
Abbreviations: CI, confidence interval; NUTS 2, Nomenclature of Territorial Units for Statistics, level 2; PR, prevalence ratio; RA, Região Autónoma (autonomous re-
gion).
a Most recent mammography performed 2 or more years ago.
b Adjusted for age and education, except in education strata.
c Based on the share of local population living in urban clusters and in urban centers according to Commission Directorates-General for Regional and Urban Policy,
Agriculture and Rural Development, Eurostat, Joint Research Centre, and the Organisation for Economic Co-operation and Development.
d Self-reported weight and height were used to compute body mass index (kg/m2), which was divided into 3 categories according to the World Health Organization
guidelines (11).
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